Incomplete non-sterile immunity to malaria is attained in endemic regions after recurrent infections by a large percentage of the adult population, who carry the malaria parasite asymptomatically. Although blood-stage Plasmodium falciparum rapidly elicits IgG responses, the target antigens of partially protective and non-protective IgG antibodies as well as the basis for the acquisition of these antibodies remain largely unknown. We performed IgG-immunomics to screen for P. falciparum antigens and to identify epitopes associated with exposure and clinical disease. Sera from malaria cases identified five prevalent antigens recognized by all analyzed patients' IgGs. For further epitope mapping, peptide microarrays designed to cover their sequences were probed with a set of 38 sera samples from adult individuals of an endemic malaria region in Ghana. Eight 20-mer peptides with the highest affinity and frequency of recognition among the population were subsequently validated with 16 sera from the same region, segregated into patients with positive or negative subclinical detection of P. falciparum.
Abstract
Incomplete non-sterile immunity to malaria is attained in endemic regions after recurrent infections by a large percentage of the adult population, who carry the malaria parasite asymptomatically. Although blood-stage Plasmodium falciparum rapidly elicits IgG responses, the target antigens of partially protective and non-protective IgG antibodies as well as the basis for the acquisition of these antibodies remain largely unknown. We performed IgG-immunomics to screen for P. falciparum antigens and to identify epitopes associated with exposure and clinical disease. Sera from malaria cases identified five prevalent antigens recognized by all analyzed patients' IgGs. For further epitope mapping, peptide microarrays designed to cover their sequences were probed with a set of 38 sera samples from adult individuals of an endemic malaria region in Ghana. Eight 20-mer peptides with the highest affinity and frequency of recognition among the population were subsequently validated with 16 sera from the same region, segregated into patients with positive or negative subclinical detection of P. falciparum.
Significant binding specificity for two immunodominant antigenic regions was uncovered within the START-related lipid transfer protein and the protein disulfide isomerase PDI8. These 20-mer peptides challenged with sera samples from children under 5 years old displayed specific IgG binding in those with detectable parasitemia, even at subclinical level. These results suggest that the humoral response against START and PDI8 antigens may be triggered even at submicroscopic parasitemia levels in children and may eventually be used to differentially diagnose subclinical malaria in children.
Significance
Malaria in Africa is a leading cause of morbidity and mortality. The reservoirs of the malaria parasite are asymptomatic patients who carry it subclinically. Identifying the parasite antigens and its fragments that trigger the most common immunity response by immunoglobulin G that partially protect people can have profound implications for both, development of a malaria vaccine and diagnosis of the subclinical parasite carriers. Antigen discovery and mapping, validated with sera from subclinical carriers, showed that immunoglobulin G responses in children against parasite's START and PDI8 may eventually be used to differentially diagnose non-infected from subclinical cases. Furthermore, anti-START and anti-PDI8 endemic immunodominance provides association of these antigens with long-term acquired immunity and immune evasion to malaria.
Introduction
Endemic Plasmodium falciparum malaria causes million clinical cases and hundreds of thousand deaths worldwide (1) , although the global disease toll probably exceed these numbers (2, 3) . Most deaths occur in sub-Saharan Africa (90%) and in children under 5 years old (70%) (1) . In non-endemic areas, malaria could also be a public health threat due to international tourism and migration to and from endemic areas, which has led to the occasional re-emergence of this parasitic disease as imported infection (4) .
In-housing vector control, elementary clinical diagnosis and therapeutic drugs are the only available management strategy for both malaria prevention and treatment in endemic regions. As a necessary step towards malaria elimination neither vaccine nor diagnostics of subclinical reservoirs are widely available. After repeated exposure to the parasite, those who survive malaria early in life eventually acquire resistance to the disease (5) , but the mechanisms that underlie this immunity remain poorly understood (6) . Landmark studies in the 1960s showed that purified IgG from malaria-immune adults transferred to acute-malaria infected children leads to reduction of both fever and parasitemia (7) , thus indicating that antibodies against P. falciparum proteins play a critical role in controlling the blood stage of the infection. However, it is still unknown which of the 5,300 proteins presently annotated in the P. falciparum genome (PlasmoDB, www.plasmodb.org) elicit the production of protective antibodies (8) . In addition to allelic variations of MHC molecules, the degree of antigen exposure, antigen abundance and host immunodominance impede that all possible antigens could be recognized by natural immune responses (9) . With regard to host immune detection of the P. falciparum parasite, pioneer studies showed that a large number of antigens are recognizable and dispersed amongst a large fraction of the proteome (10, 11) . Among these, specific epitopes that do induce a response upon immunization with whole native antigens are defined as dominant (12) . Although most of the putatively exposed parts of the Ag surface could be subject of recognition by antibodies, the selection mechanism by which only certain antigen regions become B-cell epitopes is not fully understood (13) . The accurate identification of B-cell epitopes constitutes a basis for development of antibody therapeutics (14) , peptide-based vaccines (14) (15) (16) , and immunodiagnostic tool (17) .
Previous studies in areas endemic for malaria have been carried out to identify a correlation between malaria immunity and P. falciparum-specific antibodies. These studies determined antibody reactivity against either a few selected proteins available after cloning (18) or a wider selection of the P. falciparum proteome (up to 23%) by means of microarray technology (11) . Scanty information is available about the actual immunodominant B-cell epitopes from the identified antigens. Based on the spatial structure, epitopes can be categorized as a continuous (linear or sequential) and discontinuous (nonlinear or conformational); in the latter case amino acid residues are in close contact due to the three-dimensional conformation (16, 19) . The amount of amino acid sequence in native proteins required for the correct folding of a discontinuous epitope of B cells is always greater than 20 amino acids and can reach up to 400 amino acids. Using a less stringent definition for continuity, it has been proposed that the majority of discontinuous epitopes (over 70%) are composed of 1-5 linear segments of lengths of 1-6 amino acids (20) . Currently, the Immune Epitope Database (http://www.iedb.org/home_v3.php) contains above 700 epitopes from 63 antigens of P. falciparum. Most of them have been identified in commonly identified antigens, i.e. MSP proteins (21-23), circumsporozoite protein (CSP) (24, 25) or ring-infected erythrocyte surface protein (RESA) (26) among others. Notwithstanding all these data, correlation between IgG response for the outlined P. falciparum proteins and malaria immunity have not been firmly established, suggesting that antibodies against these proteins might not play a role in protective immunity or, more likely, that IgG against single-parasite proteins are insufficient to confer protection. In addition, the identification of B-cell epitopes can also be used in the development of diagnostic tests by immunodetection approaches (27). These data highlight the importance of increasing the repertoire of antigens and epitopes naturally expressed in Plasmodium by different strategies.
In an effort to expand the search of P. falciparum antigens and immunodominant epitopes, we first analyzed immunoproteomic profiles shown in sera from patients with imported malaria. These patients living in a non-endemic region were not periodically re-infected after other continuous P. falciparum infections, but occasionally when they visit transiently their home country of endemic malaria. Thus, their humoral immune status may hypothetically reflect a selection for pre-immunogenic anti-P. falciparum IgG antibodies, eventually directed against epitopes that suppressed acute symptoms.
The identification of IgG-reactive antigens in sera from imported malaria patients with a single recent restricted infection but with different levels of parasitemia would therefore be particularly informative, as this could allow for the identification of immunoreactive antigens that favour subclinical malaria and therefore may be relevant for both immunisation and diagnosis. In this work, the humoral response in imported malaria patients was analyzed for the identification of potential highly immunoreactive antigens and mapping of immunodominant epitopes using peptide microarrays. Subsequently, the specific IgG response to a selection of these epitopes in adult and child sera from a malaria endemic Ghanaian population was quantified, validating the antigens found and suggesting a possible correlation with the stage of development of the infection.
Results

Immunoproteomics of P. falciparum blood stage antigens.
The sera of 19 imported malaria patients showed P. falciparum infection through parasitological and serological analyses. Five of these patients showed clinical symptoms and were classified as imported clinical malaria (ICM) with high parasitemia.
The remaining 14 patients were identified during routine medical checks and were classified as imported subclinical malaria (ISC), since no clinical symptoms of malaria were observed in addition to a submicroscopic parasitemia. Four additional sera from individuals who had never been in malaria-endemic regions were used as control. Mean values of specific anti-P. falciparum IgG antibodies quantified by indirect ELISA did not show significant differences between both patient groups, although very large intragroup variability was observed in the ISC group ( Figure S1A ). No specific antibodies against P. falciparum were detected in unexposed controls (not shown).
Although the total amount of anti-P. falciparum antibodies remained fairly constant regardless of clinical symptoms, differences in antibody avidity were observed between serum samples of the two stages of infection; namely ISC and ICM ( Figure S1B ), suggesting that a different collection of anti-P. falciparum IgG species may exist in sera of patients with very low parasitemia (higher avidity) compared to patients with clinical symptoms (lower avidity). To further identify differential IgG reactive antigens, detailed immunoproteomics was performed. Thus, the total P. falciparum intraerythrocytic proteome obtained in 2D-PAGE from a clinical isolate, originally causing subclinical malaria (28), showed 862±14 spots within the range at 3-11 isoelectric point and 3-260 kDa molecular weight ( Figure S2 ). The corresponding 2D immunoblots using sera from imported malaria cases revealed different immunoreactivity patterns for each group of patients ( Figure S2 ). Immunoblots obtained with ICM group sera showed a higher number of immunoreactive spots than ISC group sera, suggesting that parasitemia correlates with obtaining a diverse and strong humoral immune response. In addition, ISC sera showed a predominantly acidic protein pattern, in contrast to immunoblots obtained from ICM sera that showed a wide variety of both acid and basic antigens.
The quantification of signals from all samples allowed the selection of 83 immunoreactive protein spots that were present in at least 30% of the samples from each patient group, ICM or ISC. These spots were excised from the reference 2D gel and subjected to MALDI-TOF/TOF analysis and subsequent search in P. falciparum databases for protein identification. Although nearly 60% of the removed spots could not be identified (<90 score), the remaining 34 spots ( Figure S2 ) were successfully assigned to 17 proteins, as shown in Table 1 , and classified into the main functional classes of the P. falciparum proteome (29), resulting in seven of protein fate, five of metabolism, four of cell surface or organelles and only one of transport. Although some differences were observed for antigen reactivity, none of the identified proteins appeared to be significantly associated with clinical or subclinical stages. However, with the expectation of characterizing potential differences in epitope recognition, five antigens were selected based on relative immunodominance (four of which showed a positive identification of >50% by patient sera) and computational analysis of antigen function and recognition by T and B cells (30, 31): Putative protein kinase (Q8I2Q0), Heat shock protein 70 (HSP70-2), Heat shock protein 60 (HSP60) and Star-related lipid transfer protein (START), and the Protein disulfide isomerase 8 (PDI8). Among the five selected proteins, only HSP60 and PDI8 had been reported as antigenic in previous studies (11, 32) .
Mapping linear IgG epitopes with sera from an endemic malaria region.
If any of the antigens detected in imported malaria cases are relevant to the maintenance of acquired malaria immunity, sera from asymptomatic individuals in endemic areas can be expected to contain specific antibodies against epitopes in these proteins. To analyze this possibility, random sampling of sera from patients visiting Breman-Asikuma Hospital (Ghana) for reasons other than malaria symptomatology was undertaken.
Blood samples were quantified for P. falciparum parasitemia and IgG content, and subsequently HLA genotyped. The sera were classified into two groups: adults with subclinical malaria (ASC) with low parasitemia level (<0.1%); and adults with no parasitemia (ANP), and thus no having malaria. Both groups were further subdivided by their specific anti-P. falciparum IgG contents into high (>60 µg mL -1 ) or low (<60 µg mL -1 ) IgG. A list of the 38 samples used is shown in Table S2 . Most samples used for further analysis belonged to the most frequent HLA-DRB1 genotype.
Immunoreactive epitopes in the five selected antigenic proteins were mapped by high density peptide microarrays designed to contain 15-mer amino acid sequence overlapped by the following 14 residues in the next 15-mer peptide to cover the whole sequence of the selected antigens. The reactivity of IgG antibodies present in 38 serum samples from the malaria endemic region was individually tested in the peptide microarrays. The IgG antigenicity profile of the five antigens along their sequence by these sera is shown in Figure 1 . It is noteworthy that all five antigens showed a wide distribution of regions of IgG recognition along the protein sequences. The plots shown similar recognition patterns in both ASC and ANP samples. However, the overall signal was proportionally smaller in sera with low IgG values, suggesting that the ratio between the specific fraction of anti P. falciparum IgG and the total IgG remains constant among the population studied. To identify peptides that produce consistent reactivity among serum samples, a signal cut was established in the third quartile of the intensities recorded within each serum group. Figure 2 shows the frequency of serum samples emitting a fluorescent signal above the threshold in both ASC and ANP groups at all 15-mer peptide positions in the five antigens. According to the aggregated pattern of the individual sera, the peptide recognition frequencies are distributed similarly throughout the sequence, showing an almost complete coincidence between the ASC and ANP samples, which did not allow for the identification of any specific epitope of the subclinical state.
Validation of highly immunoreactive epitopes.
At the peak IgG signal along the antigen sequences, eight 20-mer length peptides were chosen that also showed the highest frequency of recognition by individual sera.
Examples of the regions selected for START protein are depicted in Figures 1 and 2.
The sequence of the chosen peptides and their location in the antigens are shown in Table 2 . These eight synthesized peptides were tested for IgG reactivity using serum samples from the endemic malaria region. Figure 3 shows the amount of specific IgG for each 20-mer peptide detected in 8 ASC sera, 8 ANP sera and 4 control sera of individuals never exposed to the parasite. Although the signals recorded for the ANP group appear to be consistently higher than those found in the ASC group, no statistically significant differences could be determined for any of the peptides (P<0.05).
When immunoreactivity was compared among ASC, ANP and control samples, only START and PDI8 peptides showed significant differences among them (see Figure 3 ).
These results indicate that both START and PDI8 contain immunodominant epitopes that maintain high amounts of specific IgG in the sera of populations exposed to malaria. The constant immunoreactivity observed in sera from the ANP group that has not detectable parasites suggests a long persistence of this IgG after elimination of the infection.
Since the persistence of anti-START and anti-PDI8 IgG in the adult population of the malaria-endemic region may be a consequence of repeated exposure to the parasite, it was conceivable that a less exposed population group would show a different pattern.
To test this hypothesis, serum samples from children younger than 5 years old in the same endemic area were analyzed to detect specific IgG against peptides 1.1, 1.3, 5.1 and 5.3 that were the most immunoreactive of START and PDI-8 in adults. In this trial, the sera of children with symptoms of malaria or asymptomatic, corresponding to those showing parasites by microscopic screening (parasitemia >0.1 %, clinical malaria: CCM), those for whom P. falciparum was detected only by PCR of its DNA but not by microscopy (subclinical malaria: CSC), and those who did not show the presence of the parasite by either method (CNP). The results, shown in Figure 4 , confirm the immunoreactivity of both antigens in sera collected from children, but unlike adults, the signal obtained in cases of subclinical malaria was significantly higher than the signal in uninfected cases (p<0.05).
Discussion
Despite the variety of P. falciparum antigenic proteins identified by different approaches (10, 11, (32) (33) (34) (35) , only a few have been shown to be; albeit partially, relevant to malaria immunity (10) or for detection purposes (36, 37). Previously, the humoral response to P. falciparum in patients with imported malaria was used to identify immunogenic proteins by western blot 1D analysis. (32). Here, we have used a 2D immunoproteomics approach using imported malaria patient sera to increase search resolution, mapped the position of potential epitopes in a selection of five immunodominant antigens, and validated their immunogenicity using serum samples from individuals in a malaria-endemic region. Although imported malaria samples used for immunoproteomics were classified into two groups based on different parasitemias, a clear association between individual antigens and disease stage could not be determined. In fact, no significant differences in total serum anti-P. falciparum IgG levels were found between the two groups. However, a higher overall avidity for anti-P. Eight of the 17 antigens identified by immunoproteomics had not been previously reported, including experimental approaches and computational prediction of the entire proteome (10) . This supports the notion that broad and diverse experimental approaches are necessary to obtain a more complete range of P. falciparum immunogenic proteins.
Chaperones were the most frequently occurring proteins in the fate category, including the heat shock proteins HSP70, HSP70-2, HSP70-3 and HSP60. In the metabolic category, Plasmepsins I and II, involved in hemoglobin digestion, were similarly found in sera from both imported malaria groups. Plasmepsin I has been detected in intraerythrocytic young stages whereas Plasmepsin II expression has been associated with mature stages (40) To investigate epitope immunoreactivity in the identified antigens, five of them were selected for mapping of their epitopes by humoral response with sera from an endemic malaria population. Putative protein kinase Q8I2Q0, HSP70-2, HSP60 and START were the most frequently detected antigens in ISC sera, suggesting that these proteins may induce a strong humoral response that lasts after parasite clearance. These five selected proteins are not only present in the asexual stage of merozoite (29) guaranteeing potential immunogenic contact by the host during the intraerythrocytic cycle (see Table 1 ), but have also recently been guaranteed gene expression throughout the asexual and sexual stages of the Plasmodium cycle at discrete levels (45), thus implying non-saturating exposure to the immune system. START antigen was also detected even more frequently than other well-known antigenic membrane proteins, such as MSPs. The protein disulfide isomerase PDI8 was also included in the epitope mapping as it was also detected with high frequency and its function associated with multiple proteins during the parasite cycle suggests that it may be widely exposed to the host immune system. Complete mapping of potential linear epitopes in these proteins using overlapping 15-mer peptide microarrays revealed high IgG reactivity sequences homogeneously distributed throughout the sequence in all antigens analyzed. As the collection of sera used for antigen screening was confined to asymptomatic adults, potential epitopes were expected to represent sequences associated with acquired Remarkably, only P. falciparum-infected children displayed anti-START or anti-PDI8 IgGs, indicating that the presence of these antibodies in adults may be associated with the development of acquired immunity against non-severe malaria.
Taken together, these results suggest that P. falciparum antigens involved in the maintenance of acquired immunity show a wide range of B-cell epitopes of which at least the START and PDI8 epitopes lead to the production of a long-lasting IgG response that is maintained after parasite clearance, which may be indicative of a relevant role of these antigens in naturally acquired immunity. In addition, the presence of anti-START and/or anti-PDI8 IgG in children with subclinical malaria would also be useful as a marker for such undetected reservoir infection. Thus, these epitopes could be used as a rapid method of ELISA immunodetection at large-scale in elimination programs instead of PCR diagnosis.
Materials and Methods
Sample collection and population.
Four sets of human sera were used in the present study. The first set (n=19) was obtained from adult sub-Sahara African patients resident in Spain with imported malaria detected after a recent trip from Africa (Table S1) (Table S2I ). The third set (n=20) was collected at the same location from children aged 6 weeks to 5 years old, including patients showing malaria symptoms (Table S3 ).
A fourth set of 4 European volunteers never exposed to malaria was used as a control. 
Protein extracts from in vitro cultures of Plasmodium falciparum
Clinical P. falciparum isolate UCM7 (28) from West Africa was cultured to high parasitemia (> 50%) following the previously described method (50). Briefly, the culture media consisted of standard RPMI 1640 (Sigma-Aldrich) supplemented with 0.5% Albumax I (Gibco), 100 µM Hypoxanthine (Sigma-Aldrich), 25 mM 101 HEPES (Sigma-Aldrich), 12.5 µg/mL Gentamicine (Sigma-Aldrich) and 25 mM NaHCO 3 (Sigma-Aldrich). Culture at 37°C with 5% CO 2 started by mixing a cryopreserved stock with fresh erythrocytes to achieve 1% hematocrit. Growth was monitored by microscopy in thin blood smears and media changes and synchronization steps following defined criteria (50) according to parasite stage and parasitemia.
Protein extracts from P. falciparum isolate UCM7 were obtained from three 150 ml culture flasks of infected red blood cells (iRBC) synchronized to mature forms (schizonts) at high parasitemia (50). Cultures were harvested and erythrocytes resuspended 1:1 in PBS containing 0.1% saponin to gently vortex during 15s for lysing RBC. Released parasites were centrifuged at 800xg during 5 min and the pellet was 3x washed in cold PBS to subsequently centrifuged at 15,000xg, 10 min. Pellets were solubilized in 50 mM Tris-HCl pH8 containing 50mM NaCl, 3% CHAPS, 0.5% MEGA 10 and protease inhibitor cocktail from Roche. Resuspension was gently mixed at 4°C Antibody avidity determination of sera from imported malaria patients is given in Supplementary Information.
Immunoproteomics for antigen identification
P. falciparum UCM7 extracts were run in 2D-PAGE (300 µg for mass-spectrometry identification / 150 µg for immunoblot) for subsequent Western blot analysis using sera from patients with imported malaria. Protein extract were cup loaded onto IPG strips (pH 3−11, 18 cm) previously hydrated overnight with a buffer containing 8 M urea, 2 M thiourea, 4% (w/v) CHAPS, 1.2%, DeStreak reagent and 2% ampholites pH 3-11. For first-dimensional separation, IEF was performed using the IPGphor 3 IEF system (GE Healthcare) at 20 °C. Voltage was gradually ramped in a step-and-hold manner to 1,000 V in three steps: 1 h at 120 V, 1 h at 500 V, and 2 h at 500−1,000 V. Then, voltage increased to 4,000 V in linear gradient (1,000−4,000 V) over the next 9 hours. Run terminated after ≈ 70,000 V/h. The focused strips were equilibrated twice with gentle vertical shaking. The first equilibration during 12 min was performed with a solution containing 100 mM Tris-HCl pH 8.8, 6 M urea, 30% glycerol, 2% SDS and 0.5% DTT.
In the second equilibration solution, DTT was replaced with 4.5% iodoacetamide and incubation continued 5 min. SDS-PAGE using a Ettan-Daltsix unit at 2 W/gel for 30 min followed by 20 W/gel for 4 h was run on homogeneous 12.5% pre-casted gels.
To visualize and further excise and identify protein spots, the 2D-gels loaded with 300 µg were fixed in 10% methanol/7% acetic acid for 30 min and overnight stained with Sypro Ruby (Sigma). Two 2D-gels for staining and protein-spot excising (300 µg) and 20 replicated 2D-gels for Western-blot (150 µg) were run in parallel, in group of 6, under identical voltage conditions to warrant replica. The 2D-gels loaded with 150 µg were transferred to polyvinylidene difluoride (PVDF) membranes. Transfer efficiency was confirmed by: (i) gel staining with Sypro Tangerine before transfer; and (ii) membrane staining with Sypro Ruby after transfer. Stained gels or blots were scanned in a Typhoon 9400 variable mode imager (GE Healthcare). For immunodetection with individual patient serum, the transferred PVDF membranes were blocked for 2 hours in 10% non-fat skimmed milk (w/v) in PBS containing 0.05% Tween-20 followed by overnight incubation with patient serum at 1: 10,000 dilution. Then, goat anti-human IgG HRP linked (Amersham Bioscience) as secondary antibody was incubated for 1 h at room temperature at a 1:10,000 dilution. Antigen-antibody reaction was visualized using the SuperSignal chemiluminescent substrate (Pierce) and exposure to X-ray film.
Human sera from Europeans never exposed to malaria were used as negative controls.
Gel and immunoblot images were analyzed using PDQuest software, version 8.0.1 (BioRad Laboratories Inc., Munich, Germany), and spots of interest were manually excised from the 2D gels, in-gel reduced, alkylated, and then digested with trypsin as described elsewhere (51) . Excised spots were washed twice in water, shrunk for 15 min with 100% acetonitrile, and dried in a Savant SpeedVac for 30 min. The samples were then reduced using 10 mM DTT in 25 mM ammonium bicarbonate for 30 min at 56°C and subsequently alkylated with 55 mM iodoacetamide in 25 mM ammonium bicarbonate for 20 min in the dark. Finally, samples were digested with 12.5 ng/µL sequencing grade trypsin in 25 mM ammonium bicarbonate (pH 8.5) overnight at 37 °C. After digestion, the supernatant was collected, and 1 µL was spotted onto a MALDI target plate and allowed to air-dry at room temperature. Next, 0.4 µL of a 3 mg/mL of α-cyano-4-hydroxytranscinnamic acid matrix in 50% acetonitrile was added to the dried peptide spots and allowed, again, to air-dry at room temperature. MALDI time-of-flight (TOF) MS analyses were performed in a 4800 Proteomics Analyzer MALDI-TOF/TOF mass spectrometer (Applied Biosystems, Warrington, U.K.) operated in positive reflector mode, with an accelerating voltage of 20,000 V. Mass spectra were then acquired for peptide mass fingerprinting (PMF). Proteins were identified by comparing the trypsin-digested peptide masses with the data provided in two databases (NCBI) residues and UniprotKB-SwissProt v.56.6) separately using MASCOT 1.9 (http://www.matrixscience.com) through the Global Protein Server v3.5 from Applied Biosystems. All of the identified proteins fulfilled the criterion of being significant (p < 0.005) according to probability based on the Mowse score (52) . Statistical analyses were performed using the Statgraphics Plus 5.1 software package.
High-density Peptide Arrays
Sera samples from subjects from Breman-Asikuma were tested for the recognition of peptides in arrays. They were synthesized on glass slides using photolithographic peptide array (53) using a layout with 12 identical sectors per slide. Each sector contained 6630 peptide fields. The surface coating on the slides was made by incubation of Nexterion E slides (Schott AG) with a 2% w/v linear copolymer of N,N'dimethylacrylamide and aminoethyl methacrylate as described (54) . Each sector of the arrays was incubated with a different serum diluted 1:200 in buffer (0.05 M Tris/acetate pH 8.0, 0.13 M NaCl, 0.1% v/v Tween20, 1g/L BSA) for 2 hours in after blocking.
Then, after washing in same buffer, the slides were incubated for 2 hours at room temperature with 1 µg/mL Cy3-conjugated goat anti-human IgG (H+L) (Sigma) and washed again. The slides were centrifuged in a slide spin-dryer and scanned at 1 µm resolution in an InnopSys 900 laser scanner using an excitation wavelength of 532 nm. The images were analyzed using the PepArray analysis program (Schafer-N) and the fluorescent signal in each field was calculated as the weighted average of the pixel intensities in that field. After one more wash, 100 µL of serum diluted 1:450 in wash buffer was added. After incubation at room temperature during 60 min, the supernatant was removed, the wells were washed once more and 100 µL of goat Anti-IgG-Fc HRP conjugated at 1 mg mL -1 (Bethyl) were added at 1:15000 dilution. HRP activity was detected as indicated above.
Peptide-based ELISA
23.
Rodrigues . Three different sera groups were used: asymptomatic subclinical (ASC, n=8), undetected malaria parasite (ANP, n=8) and no malaria exposed controls (NC, n=4). The 16 sera used from endemic malaria region were selected from the patients indicated with an asterisk in Table S2 . Mean values are given by horizontal lines, covered with a box depicting standard error. Whiskers represent 90% confidence interval. Ttest probability for significantly different means between groups are shown as: * P<0.05; ** P<0.01. 
*
Proteins selected for epitope mapping ** Data from Malaria Cell Atlas (45). Stage expression is indicated as follows: Ring (RG), Trophozoite (TR), Schizont (SC), All Asexual Stages (ALL) *** Data from (29). Stage expression is indicated as follows: Ring (RG), Trophozoite (TR), Schizont (SC), Merozoite (MR), Gametocyte (GM), All Erythrocytic Stages (ALL) 
